<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77222">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01889745</url>
  </required_header>
  <id_info>
    <org_study_id>2013_0361</org_study_id>
    <nct_id>NCT01889745</nct_id>
  </id_info>
  <brief_title>A Phase I Clinical Study of the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.</brief_title>
  <acronym>HX-1171</acronym>
  <official_title>A Phase I Clinical Study, Randomized, Single-blind,Placebo-controlled, Multiple Doses, Dose Escalation Study fo the Safety, Tolerability and Pharmacokinetics of HX-1171 in Healthy Male Subjects.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotoxtech Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotoxtech Co., Ltd</source>
  <oversight_info>
    <authority>Korea: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to multiple dose and dose escalation study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Single Dose
      Escalation Study of the Safety, Tolerabiluty, and Pharmacokinetics of HX-1171 in Healthy
      Male Subjects
    </textblock>
  </detailed_description>
  <overall_status>Temporarily not available</overall_status>
  <phase>N/A</phase>
  <study_type>Expanded Access</study_type>
  <study_design>N/A</study_design>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HX-1171</intervention_name>
    <description>Anti-oxidatant, Anti-inflamation</description>
    <arm_group_label>Anti-oxidatnat, Anti-Inflamation</arm_group_label>
    <other_name>1-O-hexyl-2,3,5-trimethylhydroquinone</other_name>
    <other_name>HX-1171 500mg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult males aged 20 to 40 years at screening.

          -  Be able to comply with the requirement of the study. Subject must provide written
             informed consent prior to study participation.

        Exclusion Criteria:

          -  History or presence of liver, kidney, or nervous system disease, respiratory
             disorders, endocrinological disorders, hemato-oncologic, cardiovascular or
             psychiatric or gastrointestinal disorders.

          -  History of known hypersensitivity to drugs including HX-1171.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kyun-Seop Bae, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Special City of Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://ctc.amc.seoul.kr</url>
    <description>Asan medical center</description>
  </link>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 20, 2013</lastchanged_date>
  <firstreceived_date>June 20, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
